{"author_id": "1448619461892771843", "created_at": "2022-08-08T18:46:54.000Z", "text": "Trending: S&amp;P 500\n\n$NVDA -8.46 %\n$AAPL -0.47 %\n$TWTR 1.35 %\n$TSLA 1.08 %\n$BLK 0.20 %\n$BA 1.72 %\n$DIS 2.37 %\n$PFE -0.09 %\n$AIG 1.11 %\n$PFG 1.01 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1556713580258623492"], "id": "1556713580258623492"}
{"created_at": "2022-08-08T05:45:07.000Z", "author_id": "1449258983265497088", "edit_history_tweet_ids": ["1556516839479320576"], "id": "1556516839479320576", "text": "New Free Options and Stock Discord LINK IN BIO! JOIN NOW!\n\nhttps://t.co/ZABnWuoNCf\n\n $GPRO $CLOV $MVIS $CTRM $SOS $HCMC $PFE $COIN $CGC https://t.co/JX8VNHH0jO"}
{"text": "$PFE news Pfizer to buy Global Blood Therapeutics in $5.4 bln deal", "author_id": "188901937", "id": "1556594480261713920", "edit_history_tweet_ids": ["1556594480261713920"], "created_at": "2022-08-08T10:53:38.000Z"}
{"created_at": "2022-08-08T21:33:10.000Z", "edit_history_tweet_ids": ["1556755423910211584"], "text": "RT @BertrandBio: Pfizer $PFE to Acquire Global Blood Therapeutics $GBT for $5.4 Billion to Enhance Presence in Rare Hematology - https://t.\u2026", "id": "1556755423910211584", "author_id": "1477192723"}
{"id": "1556658026249179138", "text": "RT @DeItaone: *Pfizer Agrees to Pay $68.50 a Share, or $5.4 Billion, for Global Blood Therapeutics, Sources Say -- WSJ\n$PFE", "edit_history_tweet_ids": ["1556658026249179138"], "author_id": "1478203732584243205", "created_at": "2022-08-08T15:06:09.000Z"}
{"id": "1556673699432087553", "text": "Trending: Health Tech\n\n$GBT 4.42 %\n$PFE 0.53 %\n$VTRS 7.45 %\n$BNTX -8.25 %\n$ARRY 5.38 %\n$TLRY 8.97 %\n$SWAV 1.46 %\n$RYTM 9.34 %\n$KRTX 67.41 %\n$ALVR -10.55 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1556673699432087553"], "author_id": "1448619461892771843", "created_at": "2022-08-08T16:08:26.000Z"}
{"text": "$GBT seems to be trading tight given $PFE doesn't even venture a guess as to when/if the deal will close in the press release.  Obviously the buyer is rock solid but timing matters now that rates are off the mat.", "author_id": "413405697", "id": "1556601832713195523", "edit_history_tweet_ids": ["1556601832713195523"], "created_at": "2022-08-08T11:22:51.000Z"}
{"created_at": "2022-08-08T21:46:47.000Z", "edit_history_tweet_ids": ["1556758849071235073"], "text": "Trending: Pharmaceutical\n\n$PFE 0.32 %\n$VTRS 3.70 %\n$KRTX 72.77 %\n$APDN -18.52 %\n$ATNX 20.42 %\n$LLY 0.46 %\n$CYCN 32.21 %\n$CPRX -3.14 %\n$STRO 9.20 %\n$LUMO 0.47 %\n\nhttps://t.co/WV3qS0l6fi", "id": "1556758849071235073", "author_id": "1448619461892771843"}
{"text": "$BNTX $PFE - BioNTech stock falls on Q2 miss as vaccine sales slump; eyes uptick in Q4 with Omicron shot delivery in October https://t.co/9f7HFpGwzB", "author_id": "15296897", "id": "1556597728515198976", "edit_history_tweet_ids": ["1556597728515198976"], "created_at": "2022-08-08T11:06:33.000Z"}
{"created_at": "2022-08-08T10:40:03.000Z", "author_id": "112872946", "edit_history_tweet_ids": ["1556591061795016704"], "id": "1556591061795016704", "text": "$MYOV \u2191 15% PM. \nReceived FDA Approval for Myfembree. $PFE"}
{"text": "RT @unusual_whales: Pfizer, $PFE, agrees to pay $68.50 a share, or $5.4 billion, for global blood therapeutics, $GBT.", "author_id": "1373772003191099392", "id": "1556776769620848641", "edit_history_tweet_ids": ["1556776769620848641"], "created_at": "2022-08-08T22:58:00.000Z"}
{"created_at": "2022-08-08T20:46:02.000Z", "edit_history_tweet_ids": ["1556743560614907904"], "text": "$PFE $VALN Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15\nhttps://t.co/vPfQ3GkSaW", "id": "1556743560614907904", "author_id": "1355194932445786112"}
{"edit_history_tweet_ids": ["1556618648642433024"], "author_id": "733717446", "text": "RT @BioStocks: $PFE Agrees to Pay $68.50/share, or $5.4B for $GBT -- WSJ", "created_at": "2022-08-08T12:29:41.000Z", "id": "1556618648642433024"}
{"author_id": "93142657", "created_at": "2022-08-08T17:59:08.000Z", "text": "RT @ByLizC: $PFE is going after sickle cell with today's $5.4bn $GBT buy, three years after its last deal in this disease went sideways: \nh\u2026", "edit_history_tweet_ids": ["1556701557365825536"], "id": "1556701557365825536"}
{"edit_history_tweet_ids": ["1556608599048208388"], "author_id": "95083293", "text": "$PFE\nhttps://t.co/uW5VrOs5GP\n\nPfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.", "created_at": "2022-08-08T11:49:45.000Z", "id": "1556608599048208388"}
{"edit_history_tweet_ids": ["1556620094649901056"], "author_id": "39546678", "text": "$PFE  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 400", "created_at": "2022-08-08T12:35:25.000Z", "id": "1556620094649901056"}
{"author_id": "1448619461892771843", "created_at": "2022-08-08T16:46:18.000Z", "text": "Trending: Pharmaceutical\n\n$PFE -0.40 %\n$VTRS 5.34 %\n$KRTX 61.09 %\n$ATNX 5.76 %\n$APDN -12.01 %\n$RETA -33.25 %\n$LLY -0.32 %\n$SIGA -0.99 %\n$CYCN 9.21 %\n$OCGN -2.80 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1556683229771534339"], "id": "1556683229771534339"}
{"created_at": "2022-08-08T20:28:12.000Z", "edit_history_tweet_ids": ["1556739073569603585"], "text": "Trending: Health Tech\n\n$NVAX -3.43 %\n$GBT 4.23 %\n$PFE 0.61 %\n$TLRY 10.26 %\n$BNTX -8.52 %\n$VTRS 3.70 %\n$ARRY 5.66 %\n$SWAV 5.76 %\n$SRGA 47.75 %\n$KRTX 71.00 %\n\nhttps://t.co/WV3qS0l6fi", "id": "1556739073569603585", "author_id": "1448619461892771843"}
{"created_at": "2022-08-08T04:56:53.000Z", "author_id": "238373158", "edit_history_tweet_ids": ["1556504701604139010"], "id": "1556504701604139010", "text": "RT @drippy2hard: \ud83d\udea8MARKET UPDATE + WATCHLIST\ud83d\udea8\n\nIn depth review on what to expect upcoming week!\n\nPlus 3 solid trade setups $BAC $PFE $FCX\n\n\ud83d\udc49\u2026"}
{"id": "1556644093186707457", "text": "RT @4ki4: \u301054\u5104\u30c9\u30eb\u3011\u30d5\u30a1\u30a4\u30b6\u30fc\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30d6\u30e9\u30c3\u30c9\u3092\u8cb7\u53ce\u3078\uff0d7300\u5104\u5186\u76f8\u5f53\u306e\u53d6\u5f15 - Bloomberg \nhttps://t.co/OY68ASJRKn\n\n$GBT +4%\n$PFE -0.3% https://t.co/FD75OTLixD", "author_id": "133979465", "edit_history_tweet_ids": ["1556644093186707457"], "created_at": "2022-08-08T14:10:47.000Z"}
{"edit_history_tweet_ids": ["1556614210951553025"], "author_id": "1400150367623598080", "text": "#DOW #DUPONT \n\nChems for men who like a little more #MEAT on their \"women\" \n\n\ud83c\udf08\ud83c\uddfa\ud83c\uddf8\ud83d\udcb2\n\n\ud83d\ude05\ud83d\ude02\ud83e\udd23\ud83d\ude02\ud83d\ude05\ud83e\udd27\ud83d\ude0e \n\n$XLV $CRM $VHT $BLK $STT $JPM $BK $BAC $NTRS $NBIM $MS $WFC $GS $JNJ $MRNA $PFE $BNTX $AZN $GLW $BDX $RVP $MRK $LLY $REGN $GSK $AMGN $NVAX $DD $BTI $PM $DOW $ULCC $MDLZ $CPB $EMN https://t.co/oeSedUd1nG", "created_at": "2022-08-08T12:12:03.000Z", "id": "1556614210951553025"}
{"author_id": "1478219847758540802", "created_at": "2022-08-08T17:26:39.000Z", "text": "$PFE   ~Top analyst price target for next week.,~ https://t.co/stBZiSEGK0", "edit_history_tweet_ids": ["1556693385209348098"], "id": "1556693385209348098"}
{"text": "$CRDF\n\nSeems like something may be up with $CRDF.\n\nCan $PFE walk and chew gum at the same time? https://t.co/iDqDW7YVLl", "author_id": "4496252499", "id": "1556782972493348865", "edit_history_tweet_ids": ["1556782972493348865"], "created_at": "2022-08-08T23:22:38.000Z"}
{"edit_history_tweet_ids": ["1556620485600989189"], "author_id": "1214403876188827648", "text": "RT @StockMKTNewz: Pfizer $PFE has agreed to acquire Global Blood Therapeutics $GBT for $68.50 per share in cash valuing $GBT around $5.4B", "created_at": "2022-08-08T12:36:59.000Z", "id": "1556620485600989189"}
{"text": "The biotech #acquistion spree continues! \n \n$PFE has agreed to #acquire $GBT for $68.5/per share in cash for a total cost of $5.4 billion. Read below for full details. \n#merger #biotech #Pharmaceutical #Biology #stocks #stockmarketnews \nhttps://t.co/7S64tJSW0O", "author_id": "1513886496645910530", "id": "1556594287709929478", "edit_history_tweet_ids": ["1556594287709929478"], "created_at": "2022-08-08T10:52:52.000Z"}
{"edit_history_tweet_ids": ["1556618615058735105"], "author_id": "1271220657049817088", "text": "RT @BullsCorner: \ud83d\udd25Monday Watchlist \ud83d\udd25\n\n$CCJ - Calls &gt;25.9\n$DOCU - Calls &gt;72.9\n$TWLO - Calls &gt;86.13\n$AMAT - C &gt;111.25 | P &lt;107.3\n$CCL - C &gt;10\u2026", "created_at": "2022-08-08T12:29:33.000Z", "id": "1556618615058735105"}
{"edit_history_tweet_ids": ["1556607252475281409"], "author_id": "1162662282574401537", "text": "RT @NedPagliarulo: $PFE to acquire $GBT for $68.50 per share for total value of $5.4B\n\nPR: https://t.co/IlBuWNhX1c", "created_at": "2022-08-08T11:44:24.000Z", "id": "1556607252475281409"}
{"author_id": "1460705570797850624", "created_at": "2022-08-08T17:27:25.000Z", "text": "$PFE Strike: 55.00 Expiration: 2022-12-16 Call .PFE221216C55 Price: 1.06 Size: 14960 Time: 2022-08-08 1:27:25PM\nPremium: $1,585,760.00", "edit_history_tweet_ids": ["1556693577341628416"], "id": "1556693577341628416"}
